See related SMOFlipid emulsion information |
|
Manufacturer |
Fresenius Kabi |
Distributor |
Hong Kong: Zuellig/Macau: The Glory Medicina |
Contents |
Per L Refined soya bean oil 60 g, medium-chain triglycerides 60 g, refined olive oil 50 g, fish oil (omega 3) 30 g. Energy: 2000 kCal |
Indications |
Supply of energy, essential fatty acids & omega 3 fatty acids to patients as part of parenteral nutrition when oral or enteral nutrition is impossible, insufficient or contraindicated.
Click to view SMOFlipid detailed prescribing infomation |
Dosage |
IV infusion into peripheral or central vein. Adult 1-2 g fat/kg body wt/day at an infusion rate of 0.125 g fat/kg body wt/hr. Max infusion rate: 0.15 g fat/kg body wt/hr. Childn Max daily dose: 3 g fat/kg body wt. Max infusion rate: 0.15 g fat/kg body wt/hr. Neonate & infant Initially 0.5-1 g fat/kg body wt/day followed by successive increase of 0.5-1 g fat/kg/body wt/day up to 3 g fat/kg body wt/day. Max daily dose: 3 g fat/kg body wt. Max infusion rate: 0.125 g fat/kg body wt/hr.
Click to view SMOFlipid detailed prescribing infomation |
Overdosage |
View SMOFlipid overdosage for action to be taken in the event of an overdose. |
Contraindications |
Hypersensitivity to fish, egg, soya or peanut protein. Severe hyperlipidemia, severe liver insufficiency, severe blood coagulation disorders, severe renal insufficiency w/o access to hemofiltration or dialysis, acute shock, acute pulmonary edema, hyperhydration, decompensated cardiac insufficiency, severe posttraumatic conditions, uncompensated DM, acute MI, stroke, embolism, metabolic acidosis, severe sepsis & hypotonic dehydration.
Click to view SMOFlipid detailed prescribing infomation |
Special Precautions |
Monitor capacity to eliminate fat. Patients at risk to hyperlipidemia eg w/ high lipid dosage, severe sepsis & extremely low birth wt infants. Impaired lipid metabolism eg in renal failure, DM, pancreatitis, liver impairment, hypothyroidism & sepsis. Monitor blood glucose levels, liver function tests, acid-base metabolism, fluid balance, FBC & electrolytes. Neonates & premature neonates w/ hyperbilirubinemia & pulmonary HTN. Pregnancy & lactation.
Click to view SMOFlipid detailed prescribing infomation |
Adverse Drug Reactions |
Slight increase in body temp.
View ADR Monitoring Form |
Drug Interactions |
[Click for SMOFlipid detailed prescribing infomation]
View more drug interactions with SMOFlipid |
Caution For Usage |
For caution against possible variation of physical aspect of medicine... click to view SMOFlipid detailed prescribing infomation |
Storage |
View SMOFlipid storage conditions for details to ensure optimal shelf-life. |
Description |
View SMOFlipid description for details of the chemical structure and excipients (inactive components). |
Mechanism of Action |
View SMOFlipid mechanism of action for pharmacodynamics and pharmacokinetics details. |
ATC Classification |
B05BA02 - fat emulsions ; Belongs to the class of solutions for parenteral nutrition used in I.V. solutions. |
Presentation/Packing |
Form |
Packing |
Photo |
SMOFlipid emulsion for infusion |
SMOFlipid 100 mL |
SMOFlipid 250 mL |
SMOFlipid 500 mL |
|
|
Manufacturer: |
Fresenius Kabi |
Distributor: |
Hong Kong: Zuellig
Macau: The Glory Medicina |
|
|
|
|